Enlivex Gold Sponsors Paris Summit with $18T AUM, Hosts Dinner for 40 Managers
ENLV•Enlivex is sponsoring Proof of Talk 2026 as a Gold Sponsor in Paris, joining about 2,500 decision-makers managing $18 trillion in assets. CEO Dr. Oren Hershkovitz will present the company’s integrated quality longevity therapeutics development and Rain protocol prediction markets treasury model to 40 institutional asset managers and allocators.
1. Event Sponsorship and Scale
Enlivex serves as a Gold Sponsor at Proof of Talk 2026 in Paris, an institutional digital assets summit convening approximately 2,500 senior decision-makers representing $18 trillion in assets under management. The company’s branding is featured at the Louvre Palace and Musée des Arts Décoratifs venues from June 2–3.
2. Curated Dinner Presentation
CEO Dr. Oren Hershkovitz will host an invitation-only dinner for around 40 institutional asset managers, allocators and digital asset investors. His presentation will detail how Enlivex combines clinical-stage longevity therapeutics development with a prediction markets treasury strategy anchored in the Rain protocol.
3. Dual Strategy Overview
Enlivex advances Allocetra™, an immunotherapy targeting age-related inflammatory conditions such as osteoarthritis, while operating a prediction markets treasury strategy on the Arbitrum-based Rain protocol. This integrated model aims to align its R&D pipeline with emerging digital asset infrastructure to enhance capital allocation and shareholder value.
